戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  nucleophilic fragmentation of the resulting isoxazoline.
2 e preparation of chiral 3,4,4-trisubstituted isoxazolines.
3 sfer reaction that leads to the formation of isoxazolines.
4 ed [3+2] dipolar cycloaddition gave bicyclic isoxazoline 17 in a regio- and stereoselective fashion.
5 sulfonamide groups, in conjunction with (5R)-isoxazoline (2S)-diaminopropionate stereochemistry, were
6 f antibacterial agents incorporating a novel isoxazoline A-ring surrogate.
7             The synthetic versatility of the isoxazoline allowed for a broad study of metal binding g
8          In a gratifying result, the initial isoxazoline analogue prepared was found to exhibit in vi
9  activity profile of a preliminary series of isoxazoline analogues incorporating either a C-C or N-C
10         Recently, we reported on a series of isoxazoline and isoxazole monobasic noncovalent inhibito
11                                    Using the isoxazoline as a common structural feature, three series
12 re a straightforward method employing chiral isoxazolines as key intermediates to access five differe
13 observed between this series and a series of isoxazoline-based selective GPIIbIIIa antagonists.
14 more stable and more synthetically versatile isoxazoline core.
15                                           An isoxazoline derivative of [6]-gingerol was prepared and
16  report a series of novel biaryl-substituted isoxazoline derivatives in which the biaryl moiety was d
17 ria, by screening a small library of 3-bromo-isoxazoline derivatives that inactivate the enzyme throu
18                 Herein we report a series of isoxazoline derivatives which are potent FXa inhibitors.
19                                   Nine of 17 isoxazolines, each incorporating a different potential m
20 nitrile oxide and an olefin (22) to yield an isoxazoline followed by subsequent conversion into the g
21 cation of the alpha-carbamate substituent of isoxazoline GPIIb/IIIa (alphaIIb beta3) antagonist DMP 7
22 e cycloaddition, providing novel 5-hydroxy-2-isoxazolines in high chemical yield with high levels of
23 itrones to give highly substituted 4-nitro-4-isoxazolines in high yields.
24 m alkenes leading to the direct synthesis of isoxazolines in the presence of tert-butyl nitrite, quin
25                     The previously described isoxazoline inhibitor binds at the same site as DAP but
26 DAP) and a ternary complex with NADP+ and an isoxazoline inhibitor have been solved and refined again
27                    Grignard addition to this isoxazoline intermediate followed by DCC coupling of the
28 Protonation of the nitrogen of the metalated isoxazoline intermediate results in ring opening and the
29  which underwent N-O coupling to produce new isoxazoline N-oxide derivative.
30 oximes via one-pot halogenation/oxidation of isoxazoline N-oxide derivatives is described here.
31                 In all cases, the respective isoxazoline products are produced with exquisite regio-
32 side chain at the quaternary position of the isoxazoline ring led to SK549 which showed subnanomolar
33 nter, and reversal of the orientation of the isoxazoline ring resulted in lowered potency and/or dura
34 1-propene-1,3-sultone affords the respective isoxazoline-ring-fused heterobicyclic products in modera
35 alternative basic groups, elimination of the isoxazoline stereocenter, and reversal of the orientatio
36 zations of two styrenes are involved in this isoxazoline synthesis.
37           We utilized 2 structurally related isoxazolines, which show in vitro inhibition of MIF taut
38                                        Using isoxazoline XR299 (1a) as a starting point for the desig

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。